New research, published in the journal Nature Methods, describes a new artificial intelligence (AI) technique that could help doctors predict how cancer tumours will mutate, and eventually allow them to personalise each individual’s treatment earlier.
The research was conducted at The Institute of Cancer Research (ICR) in London, and has resulted in the development of an AI technology, called Revolver (repeated evolution of cancer). Revolver recognises patterns in DNA mutations in cancer cells and uses this information to predict future genetic changes. The changing nature of tumours is one of the biggest challenges facing doctors when treating cancers, which often become resistant to drug treatments.
ICR’s chief executive Professor Paul Workman added: ‘This new approach using AI could allow treatment to be personalised in a more detailed way and at an earlier stage, tailoring it to the characteristics of each individual tumour.’